Skip to main content
TipRanks
Go Ultimate75% OFF

Cibus (CBUS) Stock Price & Analysis

685 Followers

CBUS Stock Chart & Stats

$1.13$0.04(3.67%)
At close: 4:00 PM EST
$1.25$1.5$1.75Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$1.02 - $1.14
52-Week Range
$1.02 - $4.19
Previous Close
$1.09
Volume
N/A
Average Volume (3M)
91.75K
Market Cap
$86.36M
Enterprise Value
$408.34M
Total Cash (Recent Filing)
$10.71M
Total Debt (Recent Filing)
$31.89M
Price to Earnings (P/E)
―
Beta
2.50
Next Earnings
Mar 25, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Gene-editing Platform

Cibus’s Direct Breeding platform offers a potentially durable advantage through faster trait development, multi-edit capability, and compatibility with customers’ elite germplasm. Its non-competing model may also make the technology easier for seed companies of different sizes to adopt.

Commercial Pipeline Progress

Positive field performance and movement into customer testing indicate that Cibus is progressing beyond laboratory development toward commercial validation. Advancement across rice, biofragrance, and partner-funded programs broadens potential future revenue sources and supports platform credibility.

Improving Revenue And Gross Profit

Revenue growth and the shift to positive gross profitability show improving monetization of Cibus’s collaboration and trait-development activities. Although the base remains small, sustained execution could improve operating leverage as partner programs and commercial products advance.

Bears Say

Limited Cash Runway

The short cash runway creates a durable financing constraint while Cibus continues funding development and commercialization. A near-term capital raise could reduce financial flexibility and may compete with pipeline investment, particularly before major royalty or product revenue begins.

Persistent Cash Burn

Substantial ongoing cash consumption means Cibus has not yet reached a self-funding operating model. Continued investment in the pipeline will therefore depend on financing, partners, or future commercialization proceeds, increasing exposure to execution and funding timing.

Regulatory And Revenue Timing

Dependence on future regulatory rules and downstream customer decisions can delay commercialization even when technical work progresses. Such timing uncertainty makes revenue conversion less predictable and extends the period during which Cibus must fund operations before recurring monetization develops.

Cibus News

CBUS FAQ

What was Cibus’s price range in the past 12 months?
Cibus lowest stock price was $1.02 and its highest was $4.19 in the past 12 months.
What is Cibus’s market cap?
Cibus’s market cap is $86.36M.
When is Cibus’s upcoming earnings report date?
Cibus’s next earnings report is estimated for Mar 25, 2027 (not yet confirmed), which is in 129 days.
How were Cibus’s earnings last quarter?
Cibus released its earnings results on Nov 12, 2026. The company reported -$0.29 earnings per share for the quarter, missing the consensus estimate of -$0.203 by -$0.087.
Is Cibus overvalued?
According to Wall Street analysts Cibus’s price is currently Undervalued.
Does Cibus pay dividends?
Cibus does not currently pay dividends.
What is Cibus’s EPS estimate?
Cibus’s EPS estimate is -0.19.
How many shares outstanding does Cibus have?
Cibus has 76,428,960 shares outstanding.
What happened to Cibus’s price movement after its last earnings report?
Cibus reported an EPS of -$0.29 in its last earnings report, missing expectations of -$0.203. Following the earnings report the stock price went up 3.67%.
Which hedge fund is a major shareholder of Cibus?
Hedge funds hold Cibus shares: the largest hedge-fund position in Cibus is 71,884,417 shares, and hedge funds increased their holdings by 77.6K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology